Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex moleculesSEATTLE--(BUSINESS WIRE)--As drug ...

Highly reactive organometallic reagents, like organolithiums (molecules with a carbon–lithium bond) are essential reagents in ...